Company Overview of AbGenomics Corporation
AbGenomics Corporation engages in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases and cancers. It develops therapeutic antibodies for the treatment of autoimmune diseases, allergy, asthma, transplantation rejection, and cancer. The company’s products include agonistic monoclonal antibodies, humanized monoclonal antibodies, enzyme controlling insulin sensitivity and lipid metabolism, and proteins. It also provides consulting services through its subsidiary. AbGenomics Corporation was founded in 2000 and is based in Taipei, Taiwan. AbGenomics Corporation operates as a subsidiary of AbGenomics International, Inc.
2F, No. 36, Lane. 358
Founded in 2000
886 2 2627 2707
886 2 2627 2708
Key Executives for AbGenomics Corporation
Similar Private Companies By Industry
|Hedonist Biochemical Technologies Co. Ltd||Asia|
|Charsire Biotechnology Corporation||Asia|
|Protech Pharmaservices Corporation||Asia|
|AstraZeneca Taiwan Co., Ltd.||Asia|
|Bristol-Myers Squibb (Taiwan) Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact AbGenomics Corporation, please visit www.abgenomics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.